Savara Reports Second Quarter 2022 Financial Results and Provides Business Update

Author's Avatar
Aug 11, 2022

Savara+Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the second quarter ending June 30, 2022 and provided a business update.